Vaxcyte, Inc.

PCVX

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001649094

SEC filings (opens in a new tab)

In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.

Q3 2023 vs. Q2 2023

How the institutions holding Vaxcyte, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of PCVX: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Of which not filed for Q3 2023	Q3 2023	Change
Holders	197	3	202	+8
Shares	100.1M	1.68M	101.4M	+3.00M (+3.1%)
Value	$5.00B	$83.7M	$5.17B	+$254.5M (+5.2%)

3 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Vaxcyte, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to PCVX in Q3 2023
Institution	Shares	Value	% of portfolio
Pictet Asset Management Holding SA	1,474,782	$75.2M	0.09%
Westfield Capital Management Co LP	1,003,916	$51.2M	0.35%
Eventide Asset Management, LLC	393,000	$20.0M	0.36%
California Public Employees Retirement System	103,134	$5.26M	0.00%
Comerica Bank	86,431	$4.41M	0.02%
SG Americas Securities, LLC	27,980	$1.43M	0.02%
Citadel Advisors LLC	22,106	$1.13M	0.00%
Glenmede Trust Co NA	14,938	$761.5K	0.00%
Ameriprise Financial Inc	11,679	$595.4K	0.00%
UBS Oconnor LLC	10,000	$509.8K	0.01%
Allianz Asset Management GmbH	8,500	$433.3K	0.00%
Ellsworth Advisors, LLC	7,853	$365.2K	0.13%
Brinker Capital Investments, LLC	6,255	$318.9K	0.00%
Orion Portfolio Solutions, LLC	6,255	$318.9K	0.00%
Captrust Financial Advisors	6,035	$307.7K	0.00%
Rathbone Brothers plc	4,330	$220.7K	0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	3,487	$177.8K	0.01%
KBC Group NV	1,538	$78.0K	0.00%
Clearstead Advisors, LLC	410	$20.9K	0.00%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.	62	$3.16K	0.00%
Allworth Financial LP	29	$1.48K	0.00%
Huntington National Bank	18	$918	0.00%
Global Retirement Partners, LLC	13	$623	0.00%
Cornerstone Planning Group LLC	1	$51	0.00%

Sold out (16)

Institutions that held Vaxcyte, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of PCVX in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Renaissance Technologies LLC	215,477	$10.8M
Jane Street Group, LLC	72,733	$3.63M
Walleye Capital LLC	59,041	$2.95M
Resolute Capital Asset Partners LLC	50,000	$2.50M
Voloridge Investment Management, LLC	40,764	$2.04M
Tudor Investment Corp Et Al	31,068	$1.55M
Harvest Investment Services, LLC	13,810	$689.7K
Lazard Asset Management LLC	9,268	$461.0K
Level Four Advisory Services, LLC	9,173	$458.1K
Abn Amro Investment Solutions	5,836	$291.4K
Squarepoint Ops LLC	5,140	$256.7K
Walleye Trading LLC	2,764	$138.0K
Russell Investments Group, Ltd.	805	$40.2K
Impact Partnership Wealth, LLC	29	$1.45K
Fifth Third Bancorp	19	$949
Versant Capital Management, Inc	9	$449

Not filed for Q3 2023 yet (3)

Institutions that held Vaxcyte, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PCVX in Q2 2023 that haven't filed for Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Pictet Asset Management SA	1,480,747	$73.9M
Tekla Capital Management LLC	194,232	$9.70M
First Capital Advisors Group, LLC.	100	$4.99K